SCHEMBL27841641

SCHEMBL27841641

CC(O)(F)Oc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.43
▸ CASR P41180 1/20 0.38
▸ HSD11B1 P28845 2/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ EPHX2 P34913 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19477799 0.81 GAA (0.42) GAACASRHSD11B1NFE2L2MAOA
SCHEMBL4977051 0.78 NFE2L2 (0.41) GAACASRNFE2L2MAOAMAOB
SCHEMBL20002023 0.77 GAA (0.40) GAACASRHSD11B1NFE2L2MAOA
SCHEMBL255560 0.75 GPR3 (0.52) GAACASRHSD11B1MAOBMAPT
SCHEMBL28993188 0.75 GAA (0.36) GAACASRHSD11B1NFE2L2MAOA
SCHEMBL3160868 0.74 NFE2L2 (0.39) GAACASRNFE2L2MAOAMAOB
SCHEMBL16886216 0.74 GAA (0.38) GAACASRHSD11B1NFE2L2MAOA
SCHEMBL16585297 0.74 PPARA (0.38) GAACASRNFE2L2MAOBPPARA
SCHEMBL22967387 0.73 HSPB1 (0.48) GAANFE2L2MAPTMEN1KMT2A
SCHEMBL11177838 0.72 GAA (0.44) GAAMAOAMAOBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102264695-A Haloalkyl containing compounds as cysteine protease inhibitors — 2011-11-30 — — CN disclosed
Send feedback